Related Experiment Videos
Defects in hemopoietic stem cell activity in Ikaros mutant mice
A Nichogiannopoulou1, M Trevisan, S Neben
1Cutaneous Biology Research Center, Massachusetts General Hospital, Harvard Medical School, Charlestown, Massachusetts 02129, USA.
The Journal of Experimental Medicine
|November 2, 1999
Summary
The Ikaros family of DNA binding factors is crucial for mouse hemopoietic stem cell (HSC) activity. Ikaros mutations severely impair HSC function and reduce blood cell precursors, highlighting Ikaros
Area of Science:
- Hematology
- Molecular Biology
- Genetics
Background:
- Hemopoietic stem cells (HSCs) are essential for lifelong blood cell production.
- The role of specific DNA binding factors in HSC activity requires further elucidation.
Purpose of the Study:
- To investigate the critical role of the Ikaros family of DNA binding factors in mouse HSC activity.
Main Methods:
- Analysis of Ikaros null and dominant negative mutant mice.
- Assessment of long-term repopulation capacity of HSCs.
- Quantification of hematopoietic progenitor populations (CFU-S, BFU-E).
- Flow cytometry analysis of tyrosine kinase receptor expression (flk-2, c-kit).
Main Results:
- Ikaros null mice showed a >30-fold reduction in long-term repopulation units.
- Ikaros dominant negative mutants exhibited no measurable HSC activity.
- Progressive reduction in multipotent and early erythroid precursors observed in Ikaros mutants.
- Decreased expression of flk-2 and c-kit tyrosine kinase receptors in HSC-enriched populations.
Conclusions:
- The Ikaros family of DNA binding factors is critical for maintaining hemopoietic stem cell activity in mice.
- Ikaros deficiency impacts early hematopoietic progenitor populations and receptor expression.
- Findings suggest a crucial role for Ikaros in HSC function and potentially in erythromyeloid differentiation.